Literature DB >> 29406974

Fever in the Returning Traveler.

Felicia A Scaggs Huang1, Elizabeth Schlaudecker2.   

Abstract

Millions of children travel annually, whether they are refugees, international adoptees, visitors, or vacationers. Although most young travelers do well, many develop a febrile illness during or shortly after their trips. Approaching a fever in the returning traveler requires an appropriate index of suspicion to diagnose and treat in a timely manner. As many as 34% of patients with recent travel history are diagnosed with routine infections, but serious infections such as malaria, enteric fever, and dengue fever should be on the differential diagnosis due the high morbidity and mortality in children.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Child; Fever; International travel; Returning traveler; Tropical infections

Mesh:

Year:  2018        PMID: 29406974      PMCID: PMC7135112          DOI: 10.1016/j.idc.2017.10.009

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


Key points

The initial workup of a febrile child without a clear source will be based on the history, physical examination, and potential risk factors but commonly includes laboratory testing. Malaria, enteric fever, and dengue fever are some of the most common and serious tropical infections in pediatric travelers. Clinicians need to remain up-to-date on potential etiologic factors for febrile illnesses to develop a focused plan best suited to the patient’s clinical picture.

Introduction

Millions of children travel annually, whether they are refugees, international adoptees, visitors, or vacationers.1, 2, 3, 4 In 2015, the International Tourism Organization reported 1.2 billion overseas trips.5, 6 Although most young travelers do well, many develop febrile illnesses during or shortly after their journeys. In a study of European children, 53% of all pediatric patients with travel-related infections were visiting friends and relatives (VFRs), 43.4% were tourists, and 2.4% were immigrants. Most illnesses are self-limited childhood infections that do not require subspecialist consultation. However, 28% of 24,920 ill American travelers sought care at travel clinics after returning home. Additionally, young children with fevers can present a diagnostic dilemma because they may not report symptoms and can be at risk for severe disease, such as malaria. As awareness of tropical illnesses rise in parents, such as the increase in multidrug-resistant bacteria worldwide or the emergence of epidemics with Zika virus in South America, families may be more anxious about serious infections as an etiologic factor of fevers. Approaching fevers in the returning traveler requires an appropriate index of suspicion to diagnose and treat the child in a timely manner. This article offers a framework on how to address these issues by discussing diseases based on geography, incubation period, and affected organ systems, as well as risk factors, diagnostic techniques, and resources.

General approach

A thorough history is an important initial step when evaluating a pediatric traveler with a fever (Table 1 ). Discussing a detailed travel itinerary develops a timeline of exposures that can be unique to an urban or rural setting (Table 2 ).
Table 1

Patient history for the returning traveler with fever

HistoryImplications
Travel itineraryOffers information on potential diseases based on geography and other exposures
Diet history (improperly cooked meats, unpasteurized dairy products, seafood, or contaminated water and produce)Brucellosis, Campylobacter infection, giardiasis, hepatitis A and E, listeriosis, traveler’s diarrhea, enteric fever, trichinosis, viral gastroenteritis (ie, norovirus)
Sick contacts (both abroad and since returning to the US)Routine viral or bacterial illnesses, Ebola infection, influenza, meningococcemia, tuberculosis
Fresh water exposureBacterial soft tissue infection (Aeromonas spp, atypical Mycobacterium), leptospirosis, schistosomiasis
Sexual encountersAcute human immunodeficiency virus (HIV) infection; gonorrhea; hepatitis A, B, or C infection; primary herpesvirus 1 or 2 infection; syphilis; Zika virus infection
Insect bites

Fleas: plague, murine typhus, rickettsioses

Flies: African sleeping sickness, leishmaniasis, sandfly fever

Lice: relapsing fever, rickettsioses

Reduviid bugs: Chagas disease

Mosquitoes: Chikungunya virus infection, dengue fever, filiarisis, Japanese encephalitis, West Nile virus infection, Zika virus infection

Ticks: African tick bite fever, babesiosis, Lyme disease, Q fever rickettsioses, tularemia

Animal bitesCat-scratch disease, rat bite fever, rabies, simian herpesvirus B infection
Animal exposure (including exposure to urine, stool, or animal products; eg, infected carcasses or wool)Anthrax, avian influenza, hantavirus infection, Hendra virus infection, infections from ectoparasites or endoparasites, Nipah virus infection, plague, psittacosis, toxoplasmosis
Body fluid exposures (tattoos, piercings, or medical procedures)Acute HIV infection, babesiosis, cytomegalovirus infection, hepatitis B and C, malaria, multidrug-resistant bacteria, trypanosomiasis
Medical history (diseases associated with immunosuppression; eg, malignancy, asplenia, or immunodeficiency)Cytomegalovirus infection, Epstein-Barr virus infection, fungal infection, mycobacterial infections
Vaccinations and prophylaxis (note: these interventions do not preclude infection with the pathogen prophylaxed against)Malaria prophylaxis, travel-appropriate vaccines
Table 2

Tropical causes of fever based on geography

LocationInfection
CaribbeanAcute histoplasmosis, chikungunya, cholera, dengue fever, leptospirosis, malaria (Haiti, primarily Plasmodium falciparum)
Central AmericaAcute histoplasmosis, coccidioidomycosis, dengue fever, hepatitis A and B, malaria (primarily P vivax), tuberculosis
South AmericaBartonellosis, dengue fever, malaria (primarily P vivax), enteric fever, leptospirosis, yellow fever
South Central AsiaDengue fever, enteric fever, hepatitis B, Japanese encephalitis, malaria (primarily non-falciparum Plasmodium spp), tuberculosis
Southeast AsiaChikungunya, cholera, dengue fever, hepatitis A, Japanese encephalitis, malaria (primarily non-falciparum Plasmodium spp), yellow fever
Sub-Saharan AfricaAcute schistosomiasis, enteric fever, filariasis, malaria (primarily P falciparum), meningococcus, rickettsioses, yellow fever
Patient history for the returning traveler with fever Fleas: plague, murine typhus, rickettsioses Flies: African sleeping sickness, leishmaniasis, sandfly fever Lice: relapsing fever, rickettsioses Reduviid bugs: Chagas disease Mosquitoes: Chikungunya virus infection, dengue fever, filiarisis, Japanese encephalitis, West Nile virus infection, Zika virus infection Ticks: African tick bite fever, babesiosis, Lyme disease, Q fever rickettsioses, tularemia Tropical causes of fever based on geography Many children receive vaccinations and/or antimicrobial prophylaxis, but reported adherence does not preclude an illness with a particular pathogen. Up to 75% of travelers do not adhere to the recommended malaria prophylaxis. Many travel vaccines, including typhoid vaccine, provide only partial protection despite proper administration of these immunizations. A medically complex individual may have sought care outside of the United States due to necessity or medical tourism, which can increase the risk of infection through body fluid exposures. Multidrug-resistant pathogens can also be associated with health care exposure. Up to half of hospitalized children in Zimbabwe are colonized with extended spectrum beta lactamase producing Enterobacteriaceae on admission to the hospital, a problem that is increasingly seen worldwide. Underlying medical conditions, such as asplenia or immunosuppression from chemotherapy, may predispose children to overwhelming infections and sepsis. Refugee children from countries such as Syria are susceptible to vaccine-preventable diseases such as polio due to infrastructure breakdown.

Clinical findings, diagnosis, and management

Fever is a common and anxiety-provoking sign for parents that can be exacerbated by overseas travel. Up to 34% of patients with recent travel history are diagnosed with routine infections. Of the 82,825 cases of infection in travelers from 1996 to 2011 reported to GeoSentinel, a worldwide data collection network on travel-related diseases, 4% of cases were considered to be life-threatening. A study in Swiss children showed that 0.45% of emergency room visits were due to travel-related morbidities with fever and gastrointestinal symptoms being the most common complaints in 63% and 50% of patients, respectively. The temporality of travel to the onset of fever can offer important clues to the etiologic factors of fevers (Table 3 ). Because the causes and clinical outcomes associated with fevers in pediatric travelers vary from self-limited to deadly, a systems-based approach can lead to prompt diagnosis and treatment that evaluates for the most likely and serious diseases early in the illness course.
Table 3

Incubation period for common tropical diseases causing

DiseaseIncubation Period
Incubation of <14 d
 Acute HIV7–21 d
 Arboviral infections (ie, chikungunya and Zika viruses)2–10 d
 Dengue fever4–8 d
 Enteric fever7–18 d
 Leptospirosis7–12 d
 Influenza1–3 d
 Malaria
 P falciparum6–30 d
 P vivax8 d–12 mo
 Rickettsioses3 d–3 wk
Incubation of 14 d to 6 wk
 Amebic liver abscessWeeks–months
 Hepatitis A28–30 d
 Hepatitis B infection60–150 d
 RabiesWeeks–months
 Schistosomiasis28–60 d
 TuberculosisWeeks for primary infection
 Visceral leishmaniasis2–10 mo
Incubation period for common tropical diseases causing

Fever

According to GeoSentinel, 91% of patients with an acute, life-threatening illness will present with fever. There are a broad range of potential tropical infections, including malaria, dengue fever, and enteric fever. The incidence of emerging infections such as Zika virus and chikungunya are not yet known. In both adults and children, pneumonia, sepsis, meningococcemia, and urinary tract infections that were acquired at home or overseas should be on the differential diagnosis. The initial workup of a febrile child without a clear source will be based on the history, physical examination, and risk factors but commonly includes a complete blood count, liver function tests, creatinine, urinalysis, and blood cultures.1, 3 Malaria smears are also frequently helpful. Other tests to consider include serologies for dengue fever or other potential etiologic agents, polymerase chain reaction for Zika virus or other pathogens, chest radiographs, and cultures of the urine and stool. Patients with altered mental status may require head imaging and lumbar puncture. The most common and concerning causes of fever in a returning pediatric traveler are highlighted next.

Malaria

Plasmodium falciparum malaria is one of the most common tropical infections. Approximately 15% to 20% of all imported malaria cases are diagnosed in the pediatric population in industrialized countries each year. Malaria is transmitted via the nocturnal-feeding Anopheles genus of mosquito. Children who are VFRs are more likely to become infected with malaria than traditional tourists. Nonimmune children are also susceptible to severe malaria from other malaria strains such as Plasmodium vivax and many young patients can present with atypical symptoms such as abdominal pain and vomiting. Older children may present with paroxysmal fever, fatigue, myalgias, headache, abdominal pain, back pain, hepatosplenomegaly, and hemolytic anemia. Additionally, severe malaria is more common in children after the first month of travel due to the incubation period of P falciparum (7–90 days), especially in those who visited sub-Saharan Africa.17, 18 Overall, sub-Saharan Africa is one of the most common geographic regions for acquisition, comprising 71.5% of cases according to a GeoSentinel study of travelers migrating or returning to Canada from 2004 to 2014. Malaria should remain on the differential diagnosis for up to a year in an acutely ill, febrile child after travel to an endemic area where P vivax and P ovale strains are present. Interestingly, 20% of malaria cases can be acquired during trips as short as 2 weeks with less utilization of pretravel services being a contributing factor. A minimum of 3 thick and thin blood smears must be performed before malaria can be excluded, preferably collected during febrile episodes. The specificity of blood smears is high but the sensitivity can be low depending on the experience of the individual interpreting the slides. Rapid diagnostic tests that detect specific proteins or lactate dehydrogenase are alternatives for diagnosis at medical centers with limited experience in microbiologic evaluation for malaria. The result should be confirmed, however, through the state public health department. In general, a febrile child without a localizing source or splenomegaly, thrombocytopenia, or indirect hyperbilirubinemia, in addition to exposure to an endemic area, should be presumptively approached as having malaria until an alternative diagnosis can be made. Treatment of malaria is well-established by the Centers for Disease Control and Prevention (CDC) guidelines. Children with acidosis, hypoglycemia, hyperparasitemia, end-organ dysfunction, and severe anemia meet the criteria for severe malaria and require prompt administration of parenteral medication. There is a growing body of evidence that artesunate may reduce mortality compared with quinidine and is becoming more common as first-line therapy in pediatric patients.22, 23 Artesunate must be obtained through the CDC Malaria Hotline (1–770–488–7788) because it is not routinely available in the United States. Quinidine may be initiated until the medication arrives. Completion of therapy with an oral regimen for uncomplicated chloroquine-resistant P falciparum, such as atovaquone-proguanil, can be offered when the child is able to tolerate the medications and the parasite burden has decreased to less than 1%. Severe disease is less common in P vivax and P ovale and infection can be treated with chloroquine or hydroxychloroquine in most areas outside of Indonesia and Papua New Guinea.

Enteric fever (typhoid and paratyphoid)

Enteric fever accounts for 18% of the 3655 cases with life-threatening tropical diseases reported to GeoSentinel. Most recorded cases were from the Indian subcontinent and in VFRs. Infection with Salmonella typhi and Salmonella paratyphi are clinically indistinguishable with fever, abdominal pain, nausea, vomiting, myalgias, and arthralgias. Diarrhea is greater than 2.5 times more common in infants than older children or adults, although constipation can also be seen. Patients can exhibit a typhoid mask with dull features and confusion, as well as a stepladder fever progression with rising temperatures over time in untreated individuals. Relative bradycardia and rose spots are also classic signs. Complications such as gastrointestinal bleeding are more common in young children who have been ill for 2 weeks or more. Transmission is fecal-oral, and humans, especially adults, may be chronic carriers. Diagnosis of enteric fever is confirmed through cultures. The most sensitive sterile site is bone marrow (80%–95%). Blood culture has the highest yield during the first week of illness (70%), and stool cultures are more sensitive as the duration of illness increases. Stool studies should be performed on all fellow travelers, and they must be monitored for signs of illness. Other abnormal laboratory findings include transaminitis and a normal or decreased white blood cell count. The antimicrobial of choice for treatment varies based on the area in which the infection was acquired because multidrug resistance is increasing. Empiric treatment with ceftriaxone or fluoroquinolones is typically recommended. Strains in Latin America and the Caribbean can be susceptible to ampicillin and trimethoprim-sulfamethoxazole. South and Southeast Asian serovars more frequently require azithromycin or cefixime.27, 28 Children with multidrug-resistant strains have more complications such as myocarditis and shock than children infected with susceptible strains but case fatality is similar (1.0% vs 1.3%, respectively). Relapse of infection can occur despite appropriate therapy, with the highest mortality in young children (6%).

Dengue fever

Dengue remains an important cause of fever in travelers returning from all tropical regions except Africa. The prevalence is rising, even in the United States, with 50 to 100 million global cases reported yearly and 22,000 deaths, primarily in children. Risk factors are dissimilar from those for malaria because transmission occurs in urban areas during the daytime due to the vector Aedes aegypti, whereas malaria transmission is more common in rural areas from dusk to dawn with the Anopheles species mosquito. Some patients may be asymptomatic, whereas others have hemorrhagic fever and shock. The illness presents as 3 distinct phases: (1) febrile phase over 3 to 7 days characterized by myalgias, headache, retroorbital pain, and rash; (2) critical phase of 24 to 48 days with plasma leakage; and (3) convalescent phase. A rising hemoglobin and gallbladder wall thickening due to increased vascular permeability suggests the development of severe dengue in children. Repeat infections with a different strain may lead to more severe disease. Serologies are most commonly used for diagnosis, although some rapid diagnostic tests are available. In cases in which infection is unclear, it may be helpful to repeat serologies 2 weeks after initial testing to monitor for an increase in titers. Other common laboratory findings include leukopenia and thrombocytopenia. Treatment consists of hydration and avoidance of salicylate-containing products to decrease the risk for bleeding. Children who develop severe dengue with hemorrhage and shock may require blood products. No antivirals or vaccines are currently available.

Other causes of fever

In recent years, arboviral illnesses transmitted via infected Aedes aegypti mosquitos have caused epidemics of Zika virus and chikungunya in South America. A European study of travelers returning from Brazil in 2013 to 2016 reported that of the 29% of patients with travel-related complaints, 6% had dengue fever, 3% had chikungunya, and 3% had Zika virus infection. The prevalence of yellow fever, which is seen throughout low-resource settings and shares the same vector, has remained stable. These infections are difficult to distinguish clinically with fever, retroorbital pain, conjunctivitis, and myalgias. Knowledge on perinatal infection with Zika and the neurodevelopmental sequelae of affected infants is rapidly evolving. A Canadian study found that 5% of travelers developed neurologic complications such as Guillain-Barre syndrome with Zika, suggesting there is much to learn with this disease in nonperinatally acquired infections. At this time, treatment is primarily supportive. Additional tropical diseases associated with fevers are outlined in Table 4 .
Table 4

Tropical diseases associated with fever

DiseaseEtiologic PathogenGeographic RegionsVector or ExposureIncubation PeriodPresentationDiagnosisManagement
Acute retroviral syndromeHIVWorldwide, highly prevalent in sub-Saharan AfricaAnal or vaginal sex, perinatal, needle stick, blood transfusion1–3 wkArthralgia, fever, rash, lymphadenopathy, pharyngitisHIV-1 RNA, p24 antigen, immunoassay for HIV-1 and HIV-2 antibodies (preferred)Antiretroviral therapy, consider trimethoprim-sulfamethoxazole prophylaxis
AnthraxBacillus anthracisCentral and South America, sub-Saharan Africa, Central and Southwestern Asia, Eastern EuropeIngestion or handling of contaminated meat, playing drums from contaminated hides, contaminated heroin in drug users

Cutaneous: 1–17 d

Gastrointestinal: 1–7 d

Injection: 1–4 d

Inhalation: 7–60 d

Varies with infection type; black eschar, cough, fever, nausea and vomiting, meningeal signs, severe soft tissue infection, shockBacterial culture, RT-PCRCombination antimicrobial therapy
BrucellosisBrucella speciesCentral and South America, Africa, Middle East, Mediterranean basin, Eastern EuropeUnpasteurized dairy products, undercooked contaminated meat2–4 wkFever, headache, malaise, myalgias, night sweats,Culture of sterile site (blood or bone marrow), PCRCombination antimicrobial therapy
Carrión’s disease (Oroya fever)Bartonella bacilliformis, B rochalimae, and B ancashensisSouth America, especially PeruGenus Lutzomyia (sandflies)10–210 dFever, headache, myalgias, abdominal pain, anemia followed by nodular skin lesionsBacterial cultureAntimicrobial therapy (aminoglycosides, tetracyclines, fluoroquinolones)
Cat-scratch diseaseB henselaeWorldwideScratches from infected cats or kittens1–3 wkFever, lymphadenitis, follicular conjunctivitis, encephalitisCulture, serologies, PCRUsually self-limited, antimicrobials (macrolides)
Chikungunya33Chikungunya virusAfrica, Asia, Central and South America, Pacific IslandsAedes aegypti and Aedes albopictus mosquito3–7 dFever, arthritis, headache, conjunctivitis, maculopapular rash, myalgiasVirus-specific IgM, PCRSupportive care, nonsteroidal antiinflammatory drugs for joint pain
Ebola & Marburg virus diseases40, 41Ebola virus & Marburg virusAfricaBody fluids Rousettus aegyptiacus (fruit bat), nonhuman primate contact, sex2–21 dProdrome of fever, arthralgias, headache, myalgias followed by conjunctivitis, coagulopathy, profuse diarrhea, shockAntigen detection, RT-PCR, serologiesExperimental immune therapies & antivirals, supportive care
Endemic typhusRickettsia typhiWorldwide, especially Southeast AsiaRodent fleas (eg, Xenopsylla cheopis)7–14 dFever, headache, malaise, nausea and vomiting, rashIgM and IgG ELISA, PCRAntimicrobial therapy (chloramphenicol, doxycycline)
Epidemic typhusR prowazekiiCentral Africa, Asia, Central and South AmericaPediculus humanus (human body louse)7–14 dFever, headache, malaise, nausea and vomiting, rashIgM and IgG ELISA, PCRAntimicrobial therapy (doxycycline)
Japanese encephalitisJapanese encephalitis virusAsia, Western PacificCulex species mosquito5–15 dFebrile illness, aseptic meningitis, acute encephalitisIgM ELISASupportive care
Lassa fever and other arenaviral infectionsArgentine hemorrhagic fever, Lassa virus, Lujo virus, LCMVAfrica, Asia, Europe, North America, and South AmericaRodent urine and feces2–21 dFever, myalgia, arthralgia, headache, meningeal signs, retrosternal pain, coagulopathy, birth defects (Lassa and LCMV)Cell culture, IgM ELISA, RT-PCRAntimicrobial therapy (ribavirin for Lassa fever), supportive care
LeptospirosisLeptospira speciesCaribbean, sub-Saharan Africa, South America, Southeast AsiaInfected animal body fluid or urine, contaminated water, food, or soil2–30 dFever, conjunctival suffusion, back pain, rash, diarrhea, vomiting, renal and liver failureIgM and IgG ELISA, PCRAntimicrobial therapy (penicillins, doxycycline)
Lyme diseaseBorrelia burgdorferiEurope, Northern to Central AsiaIxodes ticks3–30 dFever, cranial nerve palsy, erythema migrans, headache, malaise, myalgia, myocarditis, meningitis2-tiered serologic testing (ELISA or IFA & Western blot)Antimicrobial therapy (beta-lactams, doxycycline)
Murray Valley encephalitisMurray Valley encephalitis virusNew Guinea, Northwestern or southeastern AustraliaCulex mosquito7–28 dFever, meningeal signs, seizuresIgM ELISA, neutralizing antibodies, RT-PCRSupportive care
PlagueYersinia pestisCentral and Southern Africa, Central Asia, Northeastern South AmericaX cheopis flea1–6 dVaries with infection type; fever, lymphadenitis, overwhelming pneumonia, sepsis with gangreneCulture, serologiesAntimicrobial therapy (aminoglycoside, fluoroquinolone, tetracyclines)
PoliomyelitisEnterovirus types 1,2,3Sub-Saharan Africa, Middle East, South and Southeast AsiaFecal-oral7–21 dFlaccid paralysis, respiratory failureCell culture, NAAT, PCRSupportive care
Q feverCoxiella burnetiiAfrica, Middle East, EuropeAerosolized birth fluids or feces from infected livestock2–3 wkSelf-limiting respiratory illness, pneumonia, hepatitis, cardiac diseaseSerial IgG IFA, PCRAntimicrobial therapy (doxycycline, trimethoprim-sulfamethoxazole, fluoroquinolones)
RabiesRabies virusAfrica, Asia, Central and South AmericaSaliva from infected animal bite (especially bats)Weeks–monthsProdrome of fever, pain, paresthesias followed by hydrophobia, delirium, seizures, deathNeutralizing antibodies, RT-PCR, IFASupportive care, experimental Milwaukee protocol
Rat lungwormAngiostrongylus cantonensisCaribbean, Asia, Pacific islandsIngestion of infected snails & slugs or contaminated produce1–3 wkFever, meningeal signs, paresthesiasSerum antibodies, PCRSupportive care
Relapsing feverBorrelia recurrentisSub-Saharan AfricaPediculus humanus (human body louse)4–14 dFever, headache, myalgia, arthralgia, rashMicroscopic evaluation of blood smear, IgM and IgG ELISA, PCRAntimicrobial therapy (doxycycline)
RickettsiosesGenera Rickettsia, Orientia, Ehrlichia, Neorickettsia, Neoehrlichia, AnaplasmaAfrica, Europe, India, and Middle EastEctoparasites (fleas, lice, mites and ticks)7–14 dFever, headache, eschar (R conorii) at bite site, malaise, nausea and vomiting, rash maculopapular or petechial)Clinical diagnosis, PCR, serologies, biopsy of escharAntimicrobial therapy (doxycycline)
RVF and other bunyaviral infectionsRVF virus, CCHF, hantavirusAfrica, Eurasia, Middle East, North and South AmericaAedes species mosquito, Hyalomma ticks, infected animal carcasses, rodent urine and feces2–21 dFever, myalgia, arthralgia, headache, meningeal signs, vision loss (RVF), coagulopathy, renal failure (hantavirus), ecchymoses (CCHF)Cell culture, IgM ELISA, RT-PCRAntimicrobial therapy (ribavirin for CCHF), supportive care
RubellaRubella virusAfrica, Middle East, South and Southeast AsiaPerson-to-person and droplet14 dFever, conjunctivitis, lymphadenopathy, rash; congenital defectsSerologies, RT-PCRSupportive care
Scrub typhusOrientia tsutsugamushiAsia, Pacific regionsLarval mite (chigger)6–20 dFever, headache, malaise, nausea and vomiting, rashIgM and IgG ELISA, PCRAntimicrobial therapy (chloramphenicol, doxycycline)
Sleeping sicknessTrypanosoma bruceiSub-Saharan, Central, and Western AfricaGlossina species (tsetse) fly7–21 dFever, chancre at bite site, splenomegaly, renal failure, sleep cycle disruptionMicroscopic examination of sterile sites or chancre-tissue biopsyAntimicrobial therapy (suramin for early stage, eflornithine & nifurtimox for late stage)
TetanusClostridium tetaniWorldwide, most common rurallyContaminated wounds with dirt, excrement; punctures10 dCranial nerve palsies, muscle spasms and rigidity, respiratory failureClinical diagnosisHuman tetanus immune globulin, tetanus toxoid, supportive care
Tick-borne encephalitis39Tick-borne encephalitis virusCentral and Eastern Europe and Northern AsiaIxodes species ticks, ingestion of unpasteurized dairy products4–28 dProdrome of febrile illness followed by aseptic meningitis, encephalitis, myelitisIgM ELISA, RT-PCRSupportive care
ToxoplasmosisToxoplasma gondiiWorldwideIngestion of undercooked meat or contaminated water, cat feces5–23 dFever, lymphadenopathy, chorioretinitis, encephalitis or pneumonitis if immunocompromised; congenital syndromeSerologies, ocular examination, computed tomography or MRI for intracranial lesionsSupportive care or antimicrobial therapy (pyrimethamine, sulfadiazine, leucovorin)
Yellow fever39Yellow fever virusSub-Saharan Africa, South AmericaAedes species mosquito3–6 dFever, headache, back pain, nausea, vomiting, coagulopathy, shockRT-PCR, IgM ELISASupportive care
Zika35, 36Zika virusAfrica, Asia, South and Central AmericaAedes species mosquito, body fluids, sex3–12 dFever, arthralgia, conjunctivitis, headache, rash; congenital syndromeRT-PCR, serologiesSupportive care

Abbreviations: CCHF, Crimean-Congo hemorrhagic fever; ELISA, enzyme-linked immunoassay; Ig, immunoglobulin; IFA, immunofluorescence assay; LCMV, lymphocytic choriomeningitis; NAAT, nucleic acid amplification test; PCR, polymerase chain reaction; RT-PCR, real-time polymerase chain reaction; RVF; Rift Valley fever.

Tropical diseases associated with fever Cutaneous: 1–17 d Gastrointestinal: 1–7 d Injection: 1–4 d Inhalation: 7–60 d Abbreviations: CCHF, Crimean-Congo hemorrhagic fever; ELISA, enzyme-linked immunoassay; Ig, immunoglobulin; IFA, immunofluorescence assay; LCMV, lymphocytic choriomeningitis; NAAT, nucleic acid amplification test; PCR, polymerase chain reaction; RT-PCR, real-time polymerase chain reaction; RVF; Rift Valley fever.

Gastrointestinal Symptoms

Vomiting and diarrhea are common complaints in returning travelers. Up to 40% of children less than 2 years of age may develop diarrhea, with 15% requiring medical services. Fevers, nausea, and vomiting can be seen with norovirus that occurs worldwide and is frequently associated with contaminated food and water on cruise ships. Rotavirus, however, is one of the most frequent causes of diarrheal illnesses worldwide and is a common cause of infant mortality in low-resource settings. The hepatitides present with a broad range of disease from mild abdominal pain and vomiting to fulminant liver failure, although serious complications are uncommon in pediatric travelers. Community-acquired Clostridium difficile is uncommon in children but infection should be considered if the patient received recent antimicrobials. GeoSentinel data reported that 2% of patients diagnosed with Clostridium difficile after travel were 10 to 19 years of age. There are many other causes of both febrile and nonfebrile gastrointestinal illness in children (Table 5 ).
Table 5

Tropical diseases associated with gastrointestinal symptoms

DiseaseEtiologic PathogenGeographic RegionsVector or ExposureIncubation PeriodPresentationDiagnosisManagement
amebiasisEntamoeba histolyticaWorldwideFecal-oral, contaminated food or waterDays–weeksAbdominal cramps, watery or bloody diarrhea, weight loss, liver abscess with abdominal painMicroscopic evaluation of stool, serologiesAntimicrobial therapy (metronidazole + iodoquinol or puromycin)
CampylobacteriosisCampylobacter jejuni, Campylobacter coliWorldwideContaminated foods (raw poultry) and water, unpasteurized milk, fecal-oral2–4 dAbdominal pain, fever, bloody diarrhea, nausea and vomiting, pseudoappendicitis, reactive arthritis, Guillain-Barre syndromeStool culture, darkfield microscopy, NAATSupportive care, antimicrobial therapies (fluoroquinolone, macrolide)
Chagas diseaseT cruziCentral and South AmericaReduviid bug, contaminated food or water, blood transfusion7 dChagoma (eg, Romaña sign), ventricular arrhythmias, megacolon, megaesophagusMicroscopic evaluation of blood smear, IgM ELISA, PCR (acute disease only)Antimicrobial therapy (benznidazole, nifurtimox)
CholeraVibrio cholerae O-group 1 or O-group 139Africa, Caribbean, Southeast AsiaAquatic plants, brackish water, shellfish5 dProfuse, watery diarrhea, nausea and vomiting, muscle cramps, hypovolemic shockStool cultureSupportive care, antimicrobial therapy (azithromycin, doxycycline)
CyclosporiasisCyclospora cayetenensisWorldwideContaminated produce and water2–14 dWatery diarrhea, anorexia, weight loss, abdominal cramps, myalgias, vomitingMicroscopic evaluation of stool for oocystsAntimicrobial therapy (trimethoprim-sulfamethoxazole)
EchinococcosisEchinococcus speciesEurasia, Central and South America, AfricaContaminated dog feces, contaminated food or water5–15 yHydatid cysts in liver and lungs, abdominal pain, liver failureImaging (ultrasound, computed tomography scan), serologiesSupportive care, surgical excision if cyst >10 cm, antimicrobial therapy (albendazole, praziquantel)
Traveler’s diarrheaEnterotoxigenic Escherichia coli (ETEC)WorldwideFecal-oral, contaminated food or water9 h–3 dAbdominal pain, watery diarrheaClinical diagnosis, NAATSupportive care, antimicrobial therapy (ciprofloxacin, azithromycin)
FascioliasisFasciola hepatica and F giganticaSouth America, Middle East, Southeast AsiaWatercress or other aquatic plants, freshwater6–12 wkIntermittent, fever eosinophilia, abdominal pain, weight loss, urticaria, biliary colic, liver failureMicroscopic evaluation of stool, serologies, liver imagingAntimicrobial therapy (triclabendazole)
GiardiasisGiardia intestinalisWorldwideFecal-oral, sexual contact, contaminated water1–2 wkAbdominal pain, anorexia, foul-smelling diarrhea, flatulence, nausea, reactive arthritisMicroscopic evaluation of stool, DFAAntimicrobial therapy (metronidazole, tinidazole, nitazoxanide)
Peptic ulcer diseaseHelicobacter pyloriWorldwideFecal-oral, oral-oralUnknownEpigastric pain, nausea and vomiting, anorexia, gastric cancerFecal antigen assay, urea breath testAntimicrobial therapy (proton pump inhibitor + clarithromycin + amoxicillin)
PinwormEnterobius vermicularisWorldwideFecal-oral, contaminated objects1–2 moPerianal pruritusScotch tape test, microscopic evaluation of fingernailsAntimicrobial therapy (albendazole, pyrantel pamoate)
SarcocystosisSarcocystis speciesWorldwide, especially Southeast AsiaUndercooked beef or pork2 wkFever, malaise, myalgia, headache, cough, arthralgia, nausea and vomiting, diarrhea, palpitationsMicroscopic evaluation of stool, PCR, muscle biopsyAntimicrobial therapy (trimethoprim-sulfamethoxazole)
Soil-transmitted helminthsAscaris lumbricoides (roundworm), Ancylostoma duodenale (hookworm), Necator americanus (hookworm), Trichuris trichiura (whipworm)WorldwideFecal-oral, skin penetration with contaminated soil (hookworms)VariableAbdominal pain, malnutrition, bowel obstruction, anemia, cough, chest painMicroscopic evaluation of stoolAntimicrobial therapy (albendazole, mebendazole)
StrongyloidiasisStrongyloides stercoralisWorldwideAuto-inoculation, skin penetrationVariablePruritic rash at penetration site, serpiginous rashes (larva currens), respiratory symptoms (Löffler-like pneumonitis), abdominal pain, diarrhea, severe disease if immuno-compromisedMicroscopic evaluation of stool other body fluids if disseminated (eg, sputum, CSF)Antimicrobial therapy (ivermectin, albendazole)
TaeniasisTaenia solium (pork) and T saginata or T asiatica (beef)Central and South America, Africa, South and Southeast AsiaUndercooked contaminated pork or beef8–10 wk for T solium, 10–14 wk for T saginataAbdominal discomfort, weight loss, anorexia, perianal pruritus, insomnia, weaknessMicroscopic evaluation of stool for eggsAntimicrobial therapy (praziquantel, niclosamide unless symptomatic neurocysticercosis)
Visceral leishmaniasisLeishmania donovani and L infantum-chagasiSouth America, Central and Southwest Asia, East AfricaPhlebotomine sand fly, blood transfusionsWeeks–monthsFever, weight loss, hepatosplenomegaly, pancytopeniaLight-microscopic evaluation of specimens, culture, molecular methodsAntimicrobial therapy (amphotericin B, miltefosine)
YersiniosisYersinia enterocoliticaJapan, Northern EuropeUndercooked contaminated pork, contaminated water, unpasteurized dairy4–6 dFever, abdominal pain (pseudoappendicitis), bloody diarrhea, necrotizing enterocolitis in infants, reactive arthritis, erythema nodosumStool culture (or other body sits; eg, CSF, blood)Supportive care, antimicrobial therapy if severe (trimethoprim-sulfamethoxazole, fluoroquinolones, aminoglycosides)

Abbreviations: CSF, cerebrospinal fluid; DFA, direct fluorescent antibody.

Tropical diseases associated with gastrointestinal symptoms Abbreviations: CSF, cerebrospinal fluid; DFA, direct fluorescent antibody.

Respiratory Symptoms

In the pediatric population, common respiratory infections may be seen on return from international trips including pharyngitis, sinusitis, otitis, and pneumonia from pathogens commonly seen in the United States, such as Streptococcus pneumoniae and rhinovirus.4, 43 Local epidemiology of infections can be helpful in diagnosis and management and is available through the CDC. In some tropical regions, influenza may occur throughout the year and should hence remain on the differential for patients who warrant treatment with oseltamivir. Mycobacterium tuberculosis is an important etiologic factor of lower respiratory tract disease worldwide and should be considered in children with risk factors or who do not recover with antimicrobials for bacterial pneumonia. Of note, children younger than 3 years of age are more likely to present with miliary tuberculosis or neurologic involvement than adult patients. There are also many other less common causes of febrile respiratory tract infections (Table 6 ).
Table 6

Tropical diseases associated with respiratory symptoms

DiseaseEtiologic PathogenGeographic RegionsVector or ExposureIncubation PeriodPresentationDiagnosisManagement
Avian bird fluH5N1 and H7N9 influenza A virusEast and Southeast AsiaPoultry2–8 dFever, malaise, myalgia, headache, nasal congestion, cough, acute respiratory distress syndrome (ARDS)RT-PCRSupportive care
DiphtheriaCorynebacterium diphtheriaeAsia, South Pacific, Middle East, Eastern Europe, CaribbeanPerson-to-person (oral or respiratory droplets), fomites2–5 dFever, dysphagia, malaise, anorexia, pseudomembranesBacterial cultureSupportive care, equine diphtheria antitoxin (DAT), antimicrobial therapy (erythromycin, penicillin)
CoccidioidomycosisCoccidioides immitis and Coccidioides posadasiiCentral and South AmericaInhalation of spores from soil7–21 dFever, malaise, cough, headache, night sweats, myalgias, arthritis, rashCulture, IgM and IgG ELISA, immunodiffusion and complement fixationSupportive care, antimicrobial therapy if ill or at high risk of dissemination (amphotericin B, azoles)
HistoplasmosisHistoplasma capsulatumWorldwide, especially river valleysInhalation of spores from soil, bird droppings, bat guano3–17 dFever, headache, cough, pleuritic chest pain, malaiseCulture, microscopic examination, PCR, EIA on serum or other samples, immunodiffusion complement fixationSupportive care, antimicrobial therapy (azole for mild to moderate disease, amphotericin B for severe)
Legionellosis (Legionnaire’s disease and Pontiac fever)Legionella speciesWorldwideInhalation of freshwater aerosol2–10 dFever, headache, myalgias, pneumonia, respiratory distressUrine antigen assay, paired serologies, PCRAntimicrobial therapy (fluoroquinolones, macrolides)
MelioidosisBurkholderia pseudomalleiCentral and Southeast Asia, northern Australia, South AmericaSubcutaneous inoculation, inhalation, ingestion; body fluids1–21 dFever, cough, weight loss, pneumoniaCulture, indirect hemagglutination assayAntimicrobial therapy (ceftazidime, meropenem)
Middle Eastern Respiratory Syndrome (MERS)MERS coronavirusNorth Africa, Middle EastDromedary camel, person-to-person2–14 dFever, cough, arthralgia, diarrhea, myalgia, acute respiratory failure, multiple organ dysfunctionRT-PCRSupportive care
Pertussis (whooping cough)Bordetella pertussisWorldwidePerson-to-person (aerosolized respiratory droplets, respiratory secretions)7–10 dParoxysmal cough, post-tussive vomiting, apnea in infantsCulture, serologies, PCRAntimicrobial therapy (macrolides)
Tropical diseases associated with respiratory symptoms

Urinary Symptoms

Children who present with dysuria, hematuria, and fevers may require urinalysis and culture to evaluate for urinary tract infection and/or pyelonephritis. Gross hematuria with the passage of clots in an afebrile child with exposure to freshwater in Africa, the Middle East, China, and Southeast Asia should be tested for the helminth parasite from the genus Schistosoma via serologies or microscopic identification of eggs in stool. Praziquantel is the treatment of choice and may improve anemia and nutrition in some children. Patients who may have early disease or a high parasite burden may require a repeat treatment. Children who are at risk for sexual abuse and adolescents should undergo testing for sexually transmitted infections such as Chlamydia trachomatis and Neisseria gonorrheae.

Dermatologic Symptoms

Rashes are a source of concern for parents without the context of travel and may be even more worrisome after going abroad. The differential diagnosis includes typical childhood illnesses, such as roseola or staphylococcal cellulitis, in addition to tropical infections. A study of Canadian travelers from 2009 to 2012 found that cutaneous larva migrans (13%) and skin and soft tissue infections (12.2%) were some of the most common infectious dermatologic complaints among tourists. In countries where vaccination rates are low, varicella zoster virus or rubella may cause disease, especially in young children who have not completed their immunization series. Measles remains an important risk, with tourists comprising 44% of the 94 cases reported to GeoSentinel from 2000 to 2014, and 13% of patients being younger than 18 years of age, although this may represent underreporting due to the surveillance system’s primarily adult focus. Petechiae on the extremities in an ill-appearing child may indicate a serious systemic process such as meningococcal or rickettsial infection. There are many other infections with primarily dermatologic manifestations that may not cause fevers (Table 7 ).
Table 7

Tropical diseases associated with dermatologic symptoms

DiseaseEtiologic PathogenGeographic RegionsVector or ExposureIncubation PeriodPresentationDiagnosisManagement
B virusMacacine herpesvirus I or B virusWorldwideBites, scratches, body fluids of infected macaque3–30 dFever, headache, myalgias, vesicular lesions near exposure site with neuropathic pain, ascending encephalomyelitisPCR, virus-specific antibodiesSupportive care, postexposure prophylaxis (valacyclovir), antimicrobial therapy (acyclovir, ganciclovir)
Cutaneous leishmaniasisLeishmania speciesMiddle East, Southwest and Central Asia, North Africa, Southern Europe, Central and South AmericaPhlebotomine sand flyWeeks–monthsPapules that progress to ulcerated plaques, regional lymphadenopathy, and nodular lymphangitisLight-microscopy evaluation of specimens, cultures, molecular methodsAntimicrobial therapy (miltefosine, amphotericin B)
Cutaneous larva migransAncylostoma species (hookworms)Caribbean, Africa, Asia, South AmericaSkin contact with contaminated sand1–5 dSerpiginous track on skin with pruritus and edemaClinicalSupportive care, antimicrobial therapy if desired (albendazole, ivermectin)
Loiasis (African eye worm)Loa loaCentral and West AfricaGenus Chrysops (deerflies)7–12 dLocalized edema of extremities and joints (Calabar swelling), diffuse pruritus, eye pruritus and pain, and photophobiaMicroscopic evaluation of adult worm from eye, microscopic evaluation of microfilariae on blood smear, serologiesSurgical excision of adult worms, antimicrobial therapy (diethylcarbamazine, albendazole)
Lymphatic filariasisWuchereria bancrofti, Brugia malayi, and Brugia timoriSub-Saharan Africa, Southern Asia, Pacific Islands, South America, CaribbeanAedes, Culex, Anopheles, Mansonia mosquitoesYearsLymphatic dysfunction with affected limb edema and painMicroscopic evaluation of peripheral blood smear, serologiesAntimicrobial therapy (diethylcarbamazine, doxycycline)
MyiasisMaggots of Dermatobia hominis (human bot fly), Cochliomyia hominivorax (screw worm), and othersCentral and South America, Africa, CaribbeanBites of infected flies or egg laying on open wounds1–2 wkLocalized skin nodule, pruritus, discharge from punctumClinical, serologiesSurgical excision of larvae
Rat-bite feverStreptobacillus moniliformis and Streptobacillus minusWorldwideBites, scratches, oral secretions of infected rats; unpasteurized milk or contaminated food or water7–21 dRelapsing fever, maculopapular or purpuric rash, migratory polyarthritis, lymphadenopathyCulture, darkfield microscopy, stained peripheral blood smearAntimicrobial therapy (penicillin G)
River blindness (onchocerciasis)Onchocerca volvulusSub-Saharan Africa, Middle East, SouthAmericaGenus Simulium (blackflies)Weeks –yearsPruritic, popular rash with subcutaneous nodules, lymphadenitis, ocular lesions, vision lossMicroscopic evaluation of skin shavings with microfilariae, histologic evaluation, serologiesAntimicrobial therapy (ivermectin + doxycycline)
ScabiesSarcoptes scabiei var. HominisWorldwideProlonged skin-to-skin contact, fomites if crusted scabies2–6 wkNocturnal pruritus, papulovesicular rash, crusts and scales if crusted scabiesMicroscopic evaluation of skin scrapingAntimicrobial therapy (permethrin, ivermectin creams)
StrongyloidiasisStrongyloides stercoralis (roundworm)WorldwideSkin penetration with contaminated soilUnknownLocalized, pruritic, erythematous popular rash, pulmonary symptoms (Löffler-like pneumonitis), diarrhea, abdominal pain, eosinophilia, serpiginous urticarial rash (larva currens)Microscopic evaluation of stool, peripheral blood eosinophilia if disseminated, serologiesAntimicrobial therapy (ivermectin, albendazole)
TungiasisTunga penetrans (chigoe flea, jigger, sand flea)Africa, South AmericaSkin penetration (especially walking barefoot)1–2 dLocalized pruritus and pain with lesions and ulcerations with central black dotClinicalExtraction of flea using sterile needle
Tropical diseases associated with dermatologic symptoms

Summary

As the numbers of children who travel abroad continues to increase, clinicians need to remain up-to-date on potential etiologic factors for febrile illnesses on families’ return home. After ruling out life-threatening disorders that can be acquired locally or internationally, physicians are able to develop a focused diagnosis and management plan best suited to the patient’s clinical picture. There is a growing body of resources to assist clinicians, such as the CDC (www.cdc.gov/travel/) and GeoSentinel (www.istm.org/geosentinel) for data on epidemiology, geography, and other risk factors. In the future, physicians will need to be prepared to deal with the global epidemic of antimicrobial drug resistance, evolving epidemics and pandemics caused by emerging pathogens, reemerging infections due to vaccine hesitancy or international conflicts, and medical tourism in both healthy and medically complex children.
  46 in total

1.  Surveillance report of Zika virus among Canadian travellers returning from the Americas.

Authors:  Andrea K Boggild; Jennifer Geduld; Michael Libman; Cedric P Yansouni; Anne E McCarthy; Jan Hajek; Wayne Ghesquiere; Yazdan Mirzanejad; Jean Vincelette; Susan Kuhn; Pierre J Plourde; Sumontra Chakrabarti; David O Freedman; Kevin C Kain
Journal:  CMAJ       Date:  2017-03-06       Impact factor: 8.262

Review 2.  Approach to Fever in the Returning Traveler.

Authors:  Guy E Thwaites; Nicholas P J Day
Journal:  N Engl J Med       Date:  2017-02-09       Impact factor: 91.245

3.  Malaria in travellers returning or migrating to Canada: surveillance report from CanTravNet surveillance data, 2004-2014.

Authors:  Andrea K Boggild; Jennifer Geduld; Michael Libman; Cedric P Yansouni; Anne E McCarthy; Jan Hajek; Wayne Ghesquiere; Jean Vincelette; Susan Kuhn; David O Freedman; Kevin C Kain
Journal:  CMAJ Open       Date:  2016-07-06

4.  Arboviral and other illnesses in travellers returning from Brazil, June 2013 to May 2016: implications for the 2016 Olympic and Paralympic Games.

Authors:  Philippe Gautret; Frank Mockenhaupt; Martin P Grobusch; Camilla Rothe; Frank von Sonnenburg; Perry J van Genderen; Francois Chappuis; Hilmir Asgeirsson; Eric Caumes; Emmanuel Bottieau; Denis Malvy; Rogelio Lopez-Vélez; Mogens Jensenius; Carsten Schade Larsen; Francesco Castelli; Christophe Rapp; Vanessa Field; Israel Molina; Effrossyni Gkrania-Klotsas; Simin Florescu; David Lalloo; Patricia Schlagenhauf
Journal:  Euro Surveill       Date:  2016-07-07

5.  Update: Influenza Activity--United States and Worldwide, May 24-September 5, 2015.

Authors:  Lenee Blanton; Krista Kniss; Sophie Smith; Desiree Mustaquim; Craig Steffens; Brendan Flannery; Alicia M Fry; Joseph Bresee; Teresa Wallis; Rebecca Garten; Xiyan Xu; Anwar Isa Abd Elal; Larisa Gubareva; David E Wentworth; Erin Burns; Jacqueline Katz; Daniel Jernigan; Lynnette Brammer
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-09-18       Impact factor: 17.586

6.  Single dose metrifonate or praziquantel treatment in Kenyan children. II. Effects on growth in relation to Schistosoma haematobium and hookworm egg counts.

Authors:  L S Stephenson; M C Latham; K M Kurz; S N Kinoti
Journal:  Am J Trop Med Hyg       Date:  1989-10       Impact factor: 2.345

7.  Epidemiology of travel-associated and autochthonous hepatitis A in Austrian children, 1998 to 2005.

Authors:  Pamela Rendi-Wagner; Maria Korinek; Andrea Mikolasek; Andreas Vécsei; Herwig Kollaritsch
Journal:  J Travel Med       Date:  2007 Jul-Aug       Impact factor: 8.490

Review 8.  Treatment of malaria in the United States: a systematic review.

Authors:  Kevin S Griffith; Linda S Lewis; Sonja Mali; Monica E Parise
Journal:  JAMA       Date:  2007-05-23       Impact factor: 56.272

9.  Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.

Authors:  Arjen M Dondorp; Caterina I Fanello; Ilse C E Hendriksen; Ermelinda Gomes; Amir Seni; Kajal D Chhaganlal; Kalifa Bojang; Rasaq Olaosebikan; Nkechinyere Anunobi; Kathryn Maitland; Esther Kivaya; Tsiri Agbenyega; Samuel Blay Nguah; Jennifer Evans; Samwel Gesase; Catherine Kahabuka; George Mtove; Behzad Nadjm; Jacqueline Deen; Juliet Mwanga-Amumpaire; Margaret Nansumba; Corine Karema; Noella Umulisa; Aline Uwimana; Olugbenga A Mokuolu; Olanrewaju T Adedoyin; Wahab B R Johnson; Antoinette K Tshefu; Marie A Onyamboko; Tharisara Sakulthaew; Wirichada Pan Ngum; Kamolrat Silamut; Kasia Stepniewska; Charles J Woodrow; Delia Bethell; Bridget Wills; Martina Oneko; Tim E Peto; Lorenz von Seidlein; Nicholas P J Day; Nicholas J White
Journal:  Lancet       Date:  2010-11-07       Impact factor: 79.321

10.  Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea.

Authors:  Blaise Genton; Valérie D'Acremont; Lawrence Rare; Kay Baea; John C Reeder; Michael P Alpers; Ivo Müller
Journal:  PLoS Med       Date:  2008-06-17       Impact factor: 11.069

View more
  3 in total

1.  A Case of Severe Falciparum Malaria in a Returned Traveler.

Authors:  Q J Low; W K Lau; T H Lim; R A Lee; S W Cheo
Journal:  Malays Fam Physician       Date:  2020-11-10

Review 2.  Fever in the Returning Traveler.

Authors:  Dennis Paquet; Laura Jung; Henning Trawinski; Sebastian Wendt; Christoph Lübbert
Journal:  Dtsch Arztebl Int       Date:  2022-06-07       Impact factor: 8.251

3.  Chikungunya virus infections in Finnish travellers 2009-2019.

Authors:  A J Jääskeläinen; L Kareinen; T Smura; H Kallio-Kokko; O Vapalahti
Journal:  Infect Ecol Epidemiol       Date:  2020-08-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.